StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73−0.05 (-2.81%)

Close on Nov 18, 2026Market cap $52.74MP/E –Yield –

XBiotech net income

Net income is the profit left for shareholders after every expense, interest and tax.

XBiotech's net income for the twelve months ending Jun 30, 2026 was -$45.13M. For fiscal 2025 it was -$45.54M. The highest annual figure on record is $668.63M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$45.54M–
FY2024Dec 31, 2024-$38.53M–
FY2023Dec 31, 2023-$24.56M–
FY2022Dec 31, 2022-$32.90M–
FY2021Dec 31, 2021-$17.41M–
FY2020Dec 31, 2020-$11.22M-101.7%
FY2019Dec 31, 2019$668.63M–
FY2018Dec 31, 2018-$21.14M–
FY2017Dec 31, 2017-$33.15M–
FY2016Dec 31, 2016-$52.76M–
FY2015Dec 31, 2015-$37.48M–
FY2014Dec 31, 2014-$21.72M–
FY2013Dec 31, 2013-$9.93M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.73M–
Q1 FY2026Mar 31, 2026-$5.51M–
Q4 FY2025Dec 31, 2025-$26.89M–
Q3 FY2025Sep 30, 2025-$6.01M–
Q2 FY2025Jun 30, 2025-$1.76M–
Q1 FY2025Mar 31, 2025-$10.88M–
Q4 FY2024Dec 31, 2024-$10.51M–
Q3 FY2024Sep 30, 2024-$5.02M–
Q2 FY2024Jun 30, 2024-$13.01M–
Q1 FY2024Mar 31, 2024-$10.00M–
Q4 FY2023Dec 31, 2023-$4.64M–
Q3 FY2023Sep 30, 2023-$7.36M–
Q2 FY2023Jun 30, 2023-$8.74M–
Q1 FY2023Mar 31, 2023-$3.82M–
Q4 FY2022Dec 31, 2022-$3.20M–
Q3 FY2022Sep 30, 2022-$12.66M–
Q2 FY2022Jun 30, 2022-$11.64M–
Q1 FY2022Mar 31, 2022-$5.40M–
Q4 FY2021Dec 31, 2021-$6.47M–
Q3 FY2021Sep 30, 2021-$3.26M–
Q2 FY2021Jun 30, 2021-$5.12M–
Q1 FY2021Mar 31, 2021-$2.57M–
Q4 FY2020Dec 31, 2020-$1.84M-100.3%
Q3 FY2020Sep 30, 2020-$2.53M–
Q2 FY2020Jun 30, 2020-$6.84M–
Q1 FY2020Mar 31, 2020-$14.00K–
Q4 FY2019Dec 31, 2019$686.50M–
Q3 FY2019Sep 30, 2019-$6.15M–
Q2 FY2019Jun 30, 2019-$5.85M–
Q1 FY2019Mar 31, 2019-$5.86M–
Q4 FY2018Dec 31, 2018-$6.11M–
Q3 FY2018Sep 30, 2018-$5.05M–
Q2 FY2018Jun 30, 2018-$5.91M–
Q1 FY2018Mar 31, 2018-$4.07M–
Q4 FY2017Dec 31, 2017-$7.25M–
Q3 FY2017Sep 30, 2017-$6.21M–
Q2 FY2017Jun 30, 2017-$9.13M–
Q1 FY2017Mar 31, 2017-$10.56M–
Q4 FY2016Dec 31, 2016-$16.40M–
Q3 FY2016Sep 30, 2016-$12.48M–

More XBiotech figures

See a number that looks wrong?